Key Proteo Submits De Novo Application to FDA for its First Newborn Screening Kit – Chinook Observer
Key Proteo Submits De Novo Application to FDA for its First Newborn…
Seattle Children’s Research Institute & Genezen Partner To Advance XLA Gene Therapy
Seattle Children’s Research Institute, the research division of Seattle Children’s Hospital, and…
Genezen Announces Strategic Process Development and Manufacturing Partnership Agreement with Seattle Children’s Research Institute for X-linked Agammaglobulinemia (XLA) Cell Therapy Program
Seattle Children's Research Institute will be one of Genezen's first customers to…
Project 1: Program in Cell Signaling
Selected references Transcriptional signatures of Itk-deficient CD3+, CD4+ and CD8+ T-cells.Blomberg KE,…
Two children suffering from rare diseases treated at Delhi hospital
New Delhi, A four-year-old girl suffering from a rare congenital condition, whose…
Immunodeficiency disorders – UF Health
DefinitionImmunodeficiency disorders occur when the body's immune response is reduced or absent.…
FDA Approves Additional Prefilled Syringe Size of Hizentra
The Food and Drug Administration (FDA) has approved a new 50mL/10gm prefilled…
They thought their son had ‘stomach flu’ but he nearly died of sepsis from a rare genetic condition
SINGAPORE - When Ashton Leow had diarrhoea, vomiting and fever on a…
FDA Approves Room Temp Storage Conditions for Asceniv and Bivigam
The Food and Drug Administration (FDA) has approved the supplemental Biologics License…